Key result
Medication compliance linked to ~45% lower odds of depression in cardiovascular disease.
Why the study?
Cardiovascular diseases are a major cause of mortality globally and are often accompanied by psychological distress, which may worsen disease outcomes.
Cross-Sectional (n=420)
Yes
Odds Ratio: 0.55 (95% CI 0.36–0.83)
p-value: p=0.004
A substantial proportion of primary care patients with cardiovascular disease experience depression, anxiety, and stress, highlighting the need for routine psychological screening.
Adherence was associated with lower distress odds in CVD; hypothesis-generating and leaves causal benefits open for prospective trials.
Background: Cardiovascular diseases (CVDs) remain a major cause of mortality across the globe and are often accompanied by psychological distress, which may worsen disease outcomes. Aim: This study aimed to investigate the frequency and main predictors of depression, anxiety, and stress in patients with CVD. Settings and Design: Data were collected in primary health care centers (PHCCs) operated by the Ministry of National Guard Health Affairs in western Saudi Arabia. Methods and Materials: A cross-sectional study was conducted among adults with confirmed CVD. Psychological symptoms were assessed using the validated Arabic version of the Depression, Anxiety, and Stress Scale-21. Subscale scores were summed, categorized by standard severity levels, and analyzed using descriptive statistics and forward binary logistic regression to identify predictors exceeding the 'normal' range. Statistical Analysis Used: Data analysis was performed with IBM SPSS Statistics v31. Results: Among 420 CVD patients (mean age 57.3 ± 11.4; 45.5% female), depression, anxiety, and stress were present in 40.0%, 46.0%, and 30.0%, respectively, while 76.4% had at least one psychological distress symptom. Depression was more common in younger, female, or employed participants; anxiety in females or participants with non-CVD comorbidities or a family history of disability; and stress in participants with a family history of chronic disease or longer CVD duration. Medication adherence was protective across all outcomes. Conclusions: High rates of depression, anxiety, and stress were observed among patients with CVD. Routine psychological screening and structured psychosocial care within PHCCs are recommended.
No takes yet. Share an insight, caveat, or question.
Alzahrani et al. (2026) conducted a cross-sectional in Cardiovascular diseases (n=420). Medication compliance vs. Non-compliance was evaluated on Depression (DASS-21 severity rating above normal) (OR 0.55, 95% CI 0.36-0.83, p=0.004). Medication compliance was associated with significantly lower odds of depression (OR 0.55), anxiety (OR 0.47), and stress (OR 0.54) among patients with cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: